908 DEVICES INC. Financing Cash Flow
908 DEVICES INC. (MASS) reported Financing Cash Flow of -$1.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-11
- 908 DEVICES INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $965.00K.
- 908 DEVICES INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$2.17M.
- 908 DEVICES INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$414.00K, a 178.26% decline year-over-year.
- 908 DEVICES INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$16.00K, a 169.57% decline year-over-year.
- 908 DEVICES INC. net cash provided by (used in) financing activities for fiscal 2025 was -$697.00K.
- 908 DEVICES INC. net cash provided by (used in) financing activities for fiscal 2024 was -$376.00K.
- 908 DEVICES INC. net cash provided by (used in) financing activities for fiscal 2023 was -$15.94M, a 1451.57% decline from fiscal 2022.
- 908 DEVICES INC. net cash provided by (used in) financing activities for fiscal 2022 was $1.18M, a 98.76% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $965.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$1.20M 10-Q · filed 2026-08-11 | -$1.62M derived: sum of 3 quarters · filed 2026-08-11 | -$1.63M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$2.17M 10-Q · filed 2026-05-06 | -$2.58M derived: sum of 2 quarters · filed 2026-05-06 | -$2.60M derived: sum of 3 quarters · filed 2026-05-06 | -$2.68M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$414.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$430.00K derived: sum of 2 quarters · filed 2026-03-09 | -$508.00K derived: sum of 3 quarters · filed 2026-08-11 | -$697.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$94.00K derived: sum of 2 quarters · filed 2026-08-11 | -$283.00K 10-Q · filed 2025-11-10 | $246.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$267.00K 10-Q · filed 2026-08-11 | $262.00K derived: sum of 3 quarters · filed 2026-08-11 | $285.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$189.00K 10-Q · filed 2026-05-06 | $340.00K derived: sum of 2 quarters · filed 2026-05-06 | $363.00K derived: sum of 3 quarters · filed 2026-05-06 | $730.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $529.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $552.00K derived: sum of 2 quarters · filed 2026-03-09 | $919.00K derived: sum of 3 quarters · filed 2026-03-09 | -$376.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $390.00K derived: sum of 2 quarters · filed 2025-11-10 | -$905.00K 10-Q · filed 2025-11-10 | -$810.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $367.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$928.00K 10-Q · filed 2025-08-05 | -$833.00K derived: sum of 3 quarters · filed 2025-08-05 | -$1.08M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$1.29M 10-Q · filed 2025-05-13 | -$1.20M derived: sum of 2 quarters · filed 2025-05-13 | -$1.45M derived: sum of 3 quarters · filed 2025-05-13 | -$1.85M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$153.00K derived: sum of 2 quarters · filed 2025-03-07 | -$554.00K derived: sum of 3 quarters · filed 2025-03-07 | -$15.94M 10-K · filed 2025-03-07 |
| 2023-09-30 | -$248.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$649.00K derived: sum of 2 quarters · filed 2024-11-12 | -$16.03M 10-Q · filed 2024-11-12 | -$15.62M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$401.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$15.78M 10-Q · filed 2024-08-06 | -$15.37M derived: sum of 3 quarters · filed 2024-08-06 | -$15.20M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$15.38M 10-Q · filed 2024-05-03 | -$14.97M derived: sum of 2 quarters · filed 2024-05-03 | -$14.80M derived: sum of 3 quarters · filed 2024-05-03 | -$14.33M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $411.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $582.00K derived: sum of 2 quarters · filed 2024-03-08 | $1.05M derived: sum of 3 quarters · filed 2024-03-08 | $1.18M 10-K · filed 2024-03-08 |
| 2022-09-30 | $171.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $638.00K derived: sum of 2 quarters · filed 2023-11-07 | $768.00K 10-Q · filed 2023-11-07 | $95.30M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $467.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $597.00K 10-Q · filed 2023-08-08 | $95.13M derived: sum of 3 quarters · filed 2023-08-08 | $95.61M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $130.00K 10-Q · filed 2023-05-09 | $94.66M derived: sum of 2 quarters · filed 2023-05-09 | $95.14M derived: sum of 3 quarters · filed 2023-05-09 | $95.42M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $94.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $95.02M derived: sum of 2 quarters · filed 2023-03-15 | $95.29M derived: sum of 3 quarters · filed 2023-03-15 | $94.72M 10-K · filed 2023-03-15 |
| 2021-09-30 | $483.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $759.00K derived: sum of 2 quarters · filed 2022-11-14 | $193.00K 10-Q · filed 2022-11-14 | $137.38M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $276.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$290.00K 10-Q · filed 2022-08-09 | $136.89M derived: sum of 3 quarters · filed 2022-08-09 | $136.90M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$566.00K 10-Q · filed 2022-05-10 | $136.62M derived: sum of 2 quarters · filed 2022-05-10 | $136.62M derived: sum of 3 quarters · filed 2022-05-10 | $136.62M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $137.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $137.19M derived: sum of 2 quarters · filed 2022-03-11 | $137.19M derived: sum of 3 quarters · filed 2022-03-11 | $137.19M 10-K · filed 2022-03-11 |
| 2020-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $6.00K derived: sum of 2 quarters · filed 2021-11-04 | $9.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $4.00K 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $3.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |